|
|||||
|
|
Overall survival in patients with rheumatoid arthritis and solid malignancies receiving biologic disease-modifying antirheumatic therapy |
|
| Authors: | Pundole Xerxes Zamora Natalia V. Siddhanamatha Harish Lin Heather Tayar Jean Leung Cheuk Hong Li Liang Suarez-Almazor Maria E. |
| Affiliation: | 1.Department of Health Services Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA ;2.Sección Reumatología, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina ;3.Department of Data Integrity and Analytics, Augusta University Medical Center, Augusta, GA, USA ;4.Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA ;5.Department of General Internal Medicine, Section of Rheumatology and Clinical Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA ; |
| Abstract: | Clinical Rheumatology - The effects of biologic disease–modifying antirheumatic drugs (bDMARDs) in patients with rheumatoid arthritis (RA) and cancer are largely unknown. We examined overall... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |